Cardiff Oncology Inc (CRDF)

EBITDA Growth

34.30%

Quarterly · Period ending:

CRDF logo

CRDF EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported34.30%
CRDF Quarterly EBITDA YoY % (100.87% → 34.30%)
High-resolution chart · PNG

CRDF ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
34.3007%
8.1932%
40.1848%
8.4227%
-17.4848%
-33.2728%
-26.6082%
-22.1322%
-5.6189%
10.9943%
-7.2349%
-13.3569%
-6.2182%
-1.5599%
2.6896%
-24.7979%
-56.5132%
-105.9365%
-34.0971%
-60.146%
-66.7419%
-32.9089%
-1,908.0944%
-4.0257%
2.7035%
-4.4333%
109.1224%
-14.99%
-16.5487%
15.3656%
-33.851%
10.4223%
40.2889%
43.8848%
61.5019%
59.2164%
38.9651%
21.6171%
-6.9998%
-54.0053%
-47.3386%
-115.554%
-63.48%
-28.1078%
-578.8009%
-49.0664%
-58.294%
-13.1777%
81.603%
-193.3535%
75.8915%
-324.0493%
-320.9705%
5.494%
-1,229.7462%
-40.7141%
-93.1418%
-61.1953%
23.2769%
81.2929%
-84.2494%
-497.8525%
-42.2031%
63.0071%
100.8732%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.